Teladoc Health (TDOC) Capital Expenditures (2014 - 2026)

Teladoc Health has disclosed Capital Expenditures across 13 years of filings, most recently posting $34.2 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $34.2 million, up 1153.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $150.0 million (up 1112.89% YoY), and the FY2025 annual result was $118.6 million, up 998.81% from the prior year.
• Capital Expenditures came in at $34.2 million for Q1 2026 at Teladoc Health, down from $112.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $146.0 million in Q4 2022 to a low of -$79.0 million in Q4 2024.
• The 5-year median for Capital Expenditures is $26.9 million (2022), against an average of $19.5 million.
• Across the five-year window, Capital Expenditures surged 1746.94% in 2022 and slumped 5723.93% in 2024, its largest moves.
• Teladoc Health's Capital Expenditures stood at $146.0 million in 2022, then sank by 99.04% to $1.4 million in 2023, then plunged by 5723.93% to -$79.0 million in 2024, then surged by 242.21% to $112.3 million in 2025, then sank by 69.58% to $34.2 million in 2026.
• The last three Capital Expenditures figures came in at $34.2 million (Q1 2026), $112.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.